BBIO- Bridgebio Pharma, Inc.

Across the last three months, Bridgebio Pharma, Inc.'s insiders have reduced their positions by a net 56,980 shares worth roughly $4.6M.

BBIO sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.

Insider Ownership

Role	Insider	Shares	Value	30d
Dir	Homcy Charles J	919.9K	-	-
CEO	Kumar Neil	497.0K	$34.30M	-
CFO	Trimarchi Thomas	336.5K	$26.88M	-
Other	Apuli Maricel	122.7K	$9.80M	-
Dir	Cook Jennifer E.	120.8K	$10.15M	-

Buys and sells only

10 filings · page 19

Date	Insider	Role	Type	Shares	Price	Value	Chg%
Jan 3, 2020	Stephenson Brian C	See Remarks	Sell	10,800	$32.93	$355,683.31	-2.9%
Jan 3, 2020	Kumar Neil	See Remarks	Sell	120,000	$32.52	$3,902,416.96	-4.0%
Jan 3, 2020	Henderson Michael Thomas57	See Remarks	Sell	3,975	$33.17	$131,861.08	-2.2%
Dec 30, 2019	McCormick Frank	Chairman Of Oncology	Sell	100,000	$37.55	$3,755,379.27	-7.3%
Jul 3, 2019	Bridgebio Pharma, Inc.	10% Owner	Buy	882,353	$29.90	$26,382,795.88	+3.7%
Jul 1, 2019	Sinha Uma	Chief Scientific Officer	Buy	14,000	$17.00	$238,000.00	New
Jul 1, 2019	Stephenson Brian C	See Remark	Buy	55,500	$17.00	$943,500.00	+17.7%
Jul 1, 2019	Henderson Michael Thomas57	See Remarks	Buy	7,000	$17.00	$119,000.00	+4.0%
Jun 27, 2019	Viking Global Performance LLC	10% Owner	Buy	4,705,900	$17.00	$80,000,300.00	+21.5%
Jun 27, 2019	Viking Global Investors LP65	10% Owner	Buy	4,705,900	$17.00	$80,000,300.00	+21.5%